GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹152 Cr | ₹163 Cr | ₹170 Cr | ₹84 Cr | ₹88 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of GLAND PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹152 Cr |
| Mar2025 | ₹163 Cr |
| Mar2024 | ₹170 Cr |
| Mar2023 | ₹84 Cr |
| Mar2022 | ₹88 Cr |
How is Deferred Tax Assets / Liabilities of GLAND PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹152 Cr | -6.56 | |
| Mar2025 | ₹163 Cr | -4.09 | |
| Mar2024 | ₹170 Cr | 101.52 | |
| Mar2023 | ₹84 Cr | -4.05 | |
| Mar2022 | ₹88 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹55,755.2 Cr | 2.4% | 10.5% | 80.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,944.0 Cr | -2% | 6% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,962.0 Cr | -4% | 22.9% | 75.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,391.0 Cr | -1.8% | 1.8% | 21.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,267.0 Cr | -0.4% | 13.1% | 13.7% | Stock Analytics | |
| CIPLA | ₹112,620.0 Cr | -0.9% | 4.5% | -8% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 2.4% |
10.5% |
80.3% |
| SENSEX | 1.4% |
12.8% |
-1.7% |
You may also like the below Video Courses